Sort:
Open Access Research Article Issue
TAK1 activates PANoptosis through the NF-κB signalling pathway to delay diabetic wound healing
Burns & Trauma 2026, 14(1): tkag001
Published: 06 January 2026
Abstract PDF (4.2 MB) Collect
Downloads:3
Background

PANoptosis is a comprehensive form of cell death regulation that involves the interplay of pyroptosis, apoptosis, and necrosis. As a key regulator of PANoptosis, TAK1 plays a crucial role in multiple cell death pathways. However, its specific mechanism in the process of diabetic wound (DW) healing remains unclear. This study aimed to explore the role of TAK1 in regulating PANoptosis and its impact on DW healing.

Methods

We used immunofluorescence, TUNEL staining, and EthD-Ⅲ staining to analyse the relationship between TAK1 activity and PANoptosis. RNA sequencing was used to investigate the regulatory role of TAK1 and the NF-κB pathway under high-glucose conditions. Additionally, molecular docking and coimmunoprecipitation experiments were performed to verify the interaction between TAK1 and p65. Finally, a mouse model was used to study the effects of TAK1 knockdown on wound healing.

Results

Our findings revealed that PANoptosis is significantly present in DW, with markedly upregulated TAK1 expression under high-glucose conditions. The inhibition of TAK1 expression significantly reduced cell death and promoted cell proliferation and migration. Mechanistically, TAK1 interacts with p65 through the NF-κB pathway, activating downstream signals that exacerbate cell damage in a high-glucose environment. TAK1 knockdown significantly suppressed PANoptosis, promoted microvascular and collagen formation, reduced inflammation, and further accelerated wound healing.

Conclusion

TAK1 regulates PANoptosis by activating the NF-κB signalling pathway, thereby playing a crucial role in DW healing. Inhibiting TAK1 may represent a potential strategy to improve wound healing, with significant potential for clinical application.

Open Access Full Length Article Issue
Non-canonical role of “S6K1–SGK1” pathway in neuronal necroptosis following traumatic brain injury
Genes & Diseases 2026, 13(4)
Published: 03 October 2025
Abstract PDF (15.6 MB) Collect
Downloads:1

Traumatic brain injury (TBI) is characterized by high rates of death and disability. Necroptosis is reported to be involved in neuronal death after TBI. However, additional molecules and related mechanisms underlying necroptosis, particularly during TBI, remain to be elucidated. mTOR and two of its three substrates (4EBP1 and ULK1) are involved in necroptosis. However, direct evidence linking necroptosis to S6K, another key substrate of mTORC1, has been lacking. In this study, we aimed to investigate the regulated role of “S6K1-glucocorticoid-inducible kinase-1 (SGK1)” pathway in neuronal necroptosis after TBI. We first showed that the “S6K1–SGK1” pathway was activated during neuronal necroptosis in TNF-α/Smac mimics/Z-VAD-FMK-induced necroptotic cell model and mouse TBI model. Then, inhibition of the “S6K1–SGK1” pathway could decrease necroptosis by regulating the MLKL activation. Next, a rescue assay indicated that S6K1 may regulate necroptosis through modulating SGK1 expression, while not through binding with SGK1. Finally, S6K1 inhibition alleviated neuronal necroptosis, neuro-inflammation, and functional damage via SGK1 in mice after TBI. Our results showed a non-canonical role of “S6K1–SGK1” pathway in neuronal necroptosis following TBI in mice, which will provide a potential therapeutic target for necroptosis treatment in TBI and other necroptosis-related disorders.

Total 2